Bay Bioanalytical Laboratory (BBL) will complete its 20th year in business in 2012. We are proud to have delivered contract analytical laboratory services to over 265 clients. We have completed over 205 small molecules projects, 80% of which were New Chemical Entities (NCEs). The projects included anticancer, antimicrobial, anti-inflammatory and analgesic products. BBL has worked on a variety of combination products including drug-eluting stents, transdermal patches, insulin delivery pumps, inhalers and combination tablets.